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INTRODUCTION 
 
Over the last decades, both medical and psychological discourse on advanced 
illness and end-of-life care has steadily moved from focusing essentially on 
symptom and pain management to integrating a more person-centered approach. 
Such modification originated from a more aware attitude toward the dimensions of 
spirituality and meaning-making as important resources for coping with emotional 
and existential suffering inevitably connected with severe illness and mortality.  
In this work the themes of existential suffering and meaning will be explored, in the 
perspective of introducing the foundations and rationale of a randomized study on a 
psychotherapeutic intervention aimed at alleviating the various expressions of 
existential distress connected with facing a severe and advanced illness. 
The work will be articulated as follows: in the first chapter the concept of existential 
distress will be examined, and the main psychological and clinical conditions 
contributing to it will be considered and described. Furthermore the construct of 
post-traumatic growth will be presented, as a possible evolution of a traumatizing 
and frightening experience, including having an advanced or terminal cancer. 
The second chapter will be focused on the historical foundations of meaning-
centered psychotherapies. The constitutive postulates of existentialism and 
existential therapies will be illustrated, included the ones that most distinguished the 
existential approach from psychoanalysis, introducing a different conception of 
man. In particular, Viktor Frankl’s logotherapy principles will be analyzed, as they 
largely inspired the philosophic bases on these innovative approach to cancer 
patient.  
Subsequently, the most important meaning-centered interventions will be described: 
Meaning-Centered Group Therapy, Dignity Therapy and CaLM therapy. 
In the third chapter the experimental design of the study, the expected outcomes, 
assessment scales and final results will be illustrated. 
The forth chapter will be dedicated to an in-depth analysis of the research findings 
and of their possible implications in clinical practice as well as in further research. 
The limitations of the study will be disclosed. 
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The V chapter is the conclusive one, where the final considerations on the entire 
work will be drawn. 
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Chapter I 
THE MANIFOLD DIMENSIONS OF EXISTENTIAL 
SUFFERING 
 
What is existential distress? 
Patients with a life-threatening disease are inevitably called to confront the 
existential issue of mortality. While the modalities and mechanisms adopted in this 
complex event depend on the social, cultural, psychological and even physical 
factors which characterize the individual in that particular moment of life and 
his/her whole story, the traumatizing potentiality and the overwhelming reach of 
this circumstance is something pertinent to every human being. 
This confrontation with one’s own ultimate fears and concerns (as Yalom -1980 - 
puts it) constitutes an unavoidable challenge to psychosocial health, augmented by 
the intense distress which the disease carries with itself. These patients are in fact 
simultaneously exposed to manifold causes of loss, including physical pain and 
impairment, profound changes in family and social roles and relationships, complex 
decisions on treatment and the threat of death and dying. This problematic condition 
has been referred to as “existential distress” (Yalom 1980; Kirk et al. 2010; 
Shuman-Olivier et al. 2008). 
However, although the term sounds quite explicative of the dimensions involved 
once death has been made personal and real, it has been argued that a clear 
definition of what this indicates and of which its components are, is currently 
lacking (Portnoy et al. 2015). 
 
The necessity of a clearer definition 
In reviewing the use of the definition “existential distress” or “existential suffering”, 
Portnoy and Colleagues (2015) highlight that the term has most often been used in 
the palliative care literature to imply the loss of hope and meaning in people facing 
impending mortality. For example, The National Hospice and Palliative Care 
Organization (NHPCO) defined existential suffering as a loss of meaning, purpose, 
or hope in life (Kirk et al. 2010); and Schuman-Olivier and Colleagues (2008) 
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considered that the presence of a confrontation with the dying process is an essential 
condition for posing the diagnosis of existential suffering. The same authors 
suggested that existential distress may be categorized as acute, when the threat of 
imminent death may trigger fear and panic; subacute, which occurs when death 
would be imminent only if treatment were withdrawn or withheld; and chronic, 
when prognosis is greater than two weeks. 
Some, such as Rousseau (2001), have included a wide range of psychological 
symptoms in the definition of existential distress, such as hopelessness, 
disappointment, loss of self-esteem, remorse, meaninglessness, and a sense of loss 
of personal identity. Another author (Morita 2004) found that existential suffering 
included not only intractable feelings of meaninglessness or worthlessness, but also 
a sense of burden, dependency, death anxiety, fear, panic, the wish to control the 
time of death, and social isolation. From this analysis it is possible to gather that 
existential distress may come to include almost all psychological disturbances that 
can occur near the end of life. 
On the other hand, some have questioned whether existential suffering at the end of 
life, far from being a construct which requires interventions oriented at addressing 
and reducing it, is simply the expression of a physiological and structural part of the 
human condition (Hauser and Walsh 2009). 
This variability of conclusions and positions is comprehensible – as Portenoy 
(2015) points out - “since there are no widely accepted measures or clinical criteria 
to define existential suffering, nor any agreed upon thresholds for its refractoriness”. 
Yet, a clearer clinical conceptualization would be necessary if, in spite of the 
ambiguity about its definition, existential suffering has been accepted as an 
indication for palliative sedation by many governing bodies, such as the Royal 
Dutch Medical Association (2009), the European Association of Palliative Care 
(Cherny et al. 2009), the NHPCO (Kirk et al. 2010), and by an international 
consensus panel (de Graeff and Dean 2007). 
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Clinical conditions which can overlap with or contribute to existential distress 
Despite the absence of a universally accepted definition or measure of existential 
distress, it appears evident that this term overlaps substantively with other clinical 
constructs, particularly the ones of demoralization and impaired spiritual well-
being. 
Furthermore, although existential suffering has been distinguished from other 
psychological disturbances by its relationship with the end of life by Schuman-
Olivier et al. (2008), other authors (Lo et al. 2010) highlighted that both the 
cognitive–affective and somatic symptoms of depression grow near the end of life 
in patients with advanced cancer. In this perspective, the proximity to death may not 
be a valid discriminating circumstance between depression and existential distress 
and the condition of imminent mortality may instead be an ineluctable contextual 
factor for all psychological disturbances. Many psychosocial and psychiatric 
conditions may thus occur at the end of life which are profoundly connected with 
existential suffering. Based on a cross-sectional and longitudinal evidence, some 
authors proposed that existential suffering aspects, such as depression, 
hopelessness, and the desire for a hastened death may arise from a final common 
pathway of distress, emerging in response to the interaction of multiple disease-
related, individual and psychosocial factors (Rodin et al. 2007/2009; Braun et al. 
2007; Lo et al. 2010; Nissim et al. 2009). The most prominent of these have been 
identified in the physical burden of disease, attachment anxiety (i.e. worry about the 
availability of supportive relationships and the capacity to make use of them for 
emotional support), lower self-esteem, hopelessness and impaired spiritual well-
being (Rodin et al. 2009; Lo et al. 2010). 
The following subsections will be focused on framing the clinical conditions 
merging together into the construct of existential distress within the context of 
palliative care. 
 
Demoralization 
Demoralization was initially defined by Jerome Frank (1974) as a psychological 
condition characterized by a persistent inability to cope, together with associated 
feelings of helplessness, hopelessness, meaninglessness, subjective incompetence 
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and diminished self-esteem:“…the chief problem of all patients who come to 
psychotherapy is demoralization…the effectiveness of all psychotherapeutic schools 
lies in their ability to restore patient morale”. 
This conceptualization appeared congruent with the psychodynamic approach of the 
Diagnostic and Statistical Manual of Mental Disorders, Second Edition (DSM II) 
(APA 1968) which considered all disorders as a reaction to the environment. 
Initially Frank regarded symptoms of depression and anxiety as expressions of 
demoralization (Frank 1974), nonetheless, in 1975 Schildrkraut and Klein redefined 
demoralization as a construct separate from depression, outlining that whereas 
depressed patients experienced anhaedonia, the demoralized lost their sense of 
efficacy. Subsequently, Frank and De Figueredo further refined the definition of 
demoralization (Shader 2005) and distinguished this from depression by pointing 
out that the first was characterized by the two conditions of distress and sense of 
incompetence, as a consequence of uncertainty about what direction to take. 
Differently, depressed subjects cannot act, even if they know the proper choice to 
take. 
For De Figueiredo, who proposed to conceptualize Axis IV as the demoralization 
axis, demoralization is always abnormal, considered the severe impact that it has on 
functioning. (2000). 
Conversely, Slavney (1999) argued that demoralization – far from being a 
psychiatric disorder – was a normal response to adverse events, just like grief which 
is a non-pathologic reaction to distress but which may be worth clinical attention. 
For this reason he proposed to assign demoralization a V code. 
Eventually, research has shown that subgroups of patients with high demoralization 
did not meet DSM-IV criteria for major depression and vice versa (Rafanelli et al. 
2005; Clarke et al. 2000), indicating that demoralization is a clinical syndrome 
distinct from major depression.  
In a factor analysis Kissane (2004) identified 5 distinct dimensions of 
demoralization in 100 cancer patients: 
 loss of meaning; 
 dysphoria; 
 disheartenment; 
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 helplessness; 
 sense of failure. 
Since demoralization in the medically ill refers to the series of thought and 
emotions experienced by patients when they feel unable to cope with distress, 
treatment should address these painful affects, behaviours and cognitions. As 
demoralized patient frequently adopts an existential position which dissociate 
him/herself from the challenges of illness, help for the demoralized patient should 
be aimed at the alleviation of suffering and the promotion of his or her resilience 
resources. Understandably then, an effective approach should be predominantly 
represented by psychosocial support and psychotherapy where a “safe” and 
respectful exploration of the existential postures adopted by patient is made 
possible. In the meantime, however, timely identification and treatment of 
symptoms –when possible – is crucial. 
 
Spiritual well-being 
Spiritual well-being represents a multidimensional clinical construct that refers to 
the comfort derived from adherence to one’s values and beliefs, a sense of inner 
peace and of meaning and worth about life (Canada et al. 2008). It has been shown 
that spiritual well-being is linked not only to religiosity, but also to self-esteem, 
social relatedness, and to the absence of physical suffering (Lo et al. 2011). 
However, the boundaries between impaired spiritual well-being and demoralization 
are not clear and they both are indistinguishable from existential suffering. 
It is universally comprehended that individuals can find meaning in life at a variety 
of levels (Eckersley 2005). In their everyday lives, there are things like jobs, family, 
friends, interests and desires. Many people today find meaning in the pursuit of 
individual goals. Transcending the very personal sphere of meaning, however, there 
is also the level of identity which is profoundly rooted in nation or ethnic belonging, 
and in the characteristic features of a community. At the most fundamental, 
transcendent level, there is spiritual meaning. So that it is possible to state, with 
Eckersley (2007), that Spirituality represents the broadest and deepest form of 
connectedness. 
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As the same author described it, spirituality is indeed a most powerful form of 
connectedness and meaning (ibidem), whose primary feature is the capacity to 
transcend personal circumstances and material situations, so that it can represent a 
ultimate fortification against the assaults of human concerns. 
A measure of both balance and stability in meaning in life is crucial to personal 
wellbeing, and this seems to apply particularly to advanced cancer patients, as it has 
been suggested that a sense of meaning and a spiritual wellbeing are negative 
predictors of symptoms such as fatigue (Lewis et al. 2014), while evoking in 
patients the sources to find the necessary inner strengths, including perspective 
thinking, rituals for transcending immediate physical condition and modalities of 
coping with their illnesses. 
Unfortunately, as a recent systematic review points out, spiritual needs remain 
among the unmet needs for cancer population (Paterson et al. 2015) 
 
Depression  
There is a considerable similarity between the clinical features of depression and the 
broader definitions of existential suffering, to the point that the two conditions may 
be considered to be overlapping and mutually reinforcing states. For instance, it has 
been shown that patients with an advanced disease who have been diagnosed as 
depressed report problems and concerns related with existential issues at a 
prevalence 3-5 times higher than non-depressed patients (Wilson et al. 2007a/b) 
Indeed, Rodin and Zimmerman (2008) argue that some of the symptoms of 
existential distress can be found in the Diagnostic and Statistical Manual of Mental 
Disorders (DSM-IV-TR) criteria for major depression (American Psychiatric 
Association 2000). These include the presence, for at least two weeks, of either 
depressed mood or anhedonia, and at least four additional symptoms, among which 
are present: 
 feelings of worthlessness or guilt; 
 difficulty in thinking, concentrating, or making decisions; 
 recurrent thoughts of death or suicide. 
Evidence indicates that depression is also the most common mental health disorder 
in the palliative care settings. Lo and Colleagues (2010) identified in a study of 
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patients with metastatic cancer, with an expected survival of 12-18 months, the 
prevalence, course and predictors of depression and demoralization, showing that 
clinically significant depressive symptoms were present in 27% of the baseline 
sample. Furthermore, in separate reviews of the literature Shakin and Holland 
(1988), Green and Austin (1993) and Passik and Breitbart (1996) indicated that 
depressive symptoms are present in 30-40% of patients. Grabsch et al. (2006) in a 
study on 227 advanced breast cancer patients reported that 7% had major 
depression, and 24% met the criteria of an adjustment disorder with depressed 
mood or mixed emotional features. 
Nonetheless, several reasons often lead clinicians to be reluctant in diagnosing a 
depressive disorder in patients with advanced cancer (Maguire 1985). First, the 
specific clinical meaning of the term “depression” indicating a defined condition, is 
often made unclear by the ubiquitous use of this term in the colloquial settings. 
Moreover, such vagueness may be reinforced by the very nature of this disorder: 
depression hardly occurs in a clear categorical presentation, separating “depressed” 
from “non-depressed”, more plausibly occurring on a continuum of severity. 
Furthermore it is frequently believed that depression, even if severe, is a normal and 
adequate reaction when facing the end of life. As a consequence clinicians may 
minimize the significance of depression and think that almost all dying patients are 
depressed, as a result of their confrontation with the sadness and the sense of loss 
that this process brings about.  
This evidence is important, as long as it carries with itself consequences on 
treatment and clinical management and these barriers to the recognition and 
treatment of depression in palliative care don’t remain without consequences. In 
fact, while it is proven that not all patients with a terminal illness are depressed, 
those who are, but don’t receive an effective treatment show an increased risk to 
have difficulty in the management of physical symptoms and in their social and 
existential concerns (Wilson et al. 2007a; Chen and Chang 2004; Grassi et al. 1996). 
Also it has been indicated that for some this can end up in early admission to 
hospital or hospice (Christakis 1994 Hinton 1994). Moreover shorter survival has 
been associated with untreated clinical depression, potentially mediated by poorer 
adherence to anti-cancer treatments (Kissane, 2009). 
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Depression in cancer patients with advanced disease is optimally managed utilizing 
a combination of supportive psychotherapy, cognitive behavioral techniques and 
antidepressant medication. Psychotherapy, both individual and group, have been 
shown to effectively reduce existential distress and depression in this population 
(Kissane 2009; Henry et al. 2010). 
 
Desire for a hastened death 
In 1991, when the first English language account of euthanasia and assisted suicides 
in the Netherlands was published, it became apparent that the reasons given by the 
responsible physicians indicated forms of emotional, spiritual or psychosocial 
suffering at the basis of it. More specifically these reasons were: loss of Dignity, 
57%; pain, 46% (which shrinked to 5% when only nociceptive pain was 
considered); unworthy dying, 46%; dependence of others, 33%; and feeling tired of 
life (23%) (Chochinov and Breitbart 2009; Ruijis et al. 2014). Moreover, depression 
was common among patients requiring a hastened death, and was often untreated 
(O’Mahony et al. 2005). This clearly and dramatically illustrates how profound 
existential distress can be for a dying person. It has been demonstrated that the 
desire for a hastened death originates in the presence of multiple risk factors, 
including physical suffering, feeling like a burden to others, lowered self-esteem, 
loss of meaning, depression and demoralization (Hudson et al. 2006). The construct 
of hopelessness, moreover, has been found to be independently associated with the 
desire for hastened death and the will to live and to be a stronger predictor than 
severity of depression (Chochinov et al. 1998). Suicidal ideation or desire for a 
hastened death can be considered among the most complicated and controversial 
topics in palliative care and although the legalization of euthanasia and assisted 
suicide is taking place in several countries, in many others it still constitutes a 
source of great debate and divide. 
 
Posttraumatic growth: an opportunity elicited by existential distress 
It is universally believed that trauma carries with itself – at least in some cases - the 
possibility of achieving growth in personal and interpersonal dimensions. For 
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thousands of years philosophy and religion have recognized that suffering can make 
man wiser, stronger, and even closer to the “truth”. 
In the last two decades, mostly as a consequence of positive psychology, an area of 
research has developed, aimed at scientifically inquiring the positive outcomes of 
traumatic experiences (Tedeschi et al. 1998). 
In scientific literature, a rich gamut of terms has been used to indicate positive 
changes occurring after a traumatic experience (Linley and Joseph 2004). In the 
present work, we choose to use the term post-traumatic growth for its strong 
theoretical and empirical basis, and its clear correlation to events which are sensu 
stricto traumatic, and not simply distressing. 
Tedeschi and collegues (1998) defined post-traumatic growth as the tendency, after 
a trauma, to show positive changes in three principal areas, including perception of 
self, interpersonal relationships and philosophy of life. As a result of a highly 
challenging experience, thus, some report more meaningful relationships, a higher 
appreciation for life, and an increased sense of connectedness with existential and 
spiritual sources of meaning. 
Posttraumatic growth has been showed in association with several variables, among 
which: time past the event (Cordova et al. 2001; Manne et al. 2004), age (Davis et 
al. 1998; Evers et al. 2001; Manne et al., 2004; Widows et al. 2005), gender (Park et 
al. 1996; Tedeschi e Calhoun 1996), social support (O’Leary et al. 1998), positive 
emotions (Fredrickson et al. 2003; Evers et al. 2001) and coping strategies (Armeli 
et al. 2001; Cordova et al., 2001; Frazier et al. 2004; Park et al. 1996). 
Initially, the experience of posttraumatic growth was studied in survivors of war or 
natural disasters; more recently, a review by Linley and Joseph (2004) has 
documented the possibility of positive changes as a result of a wide range of 
negative events, such as grief, life-threatening diseases (cancer, HIV, heart attack), 
and sexual abuse. 
Cancer is then rightly considered a traumatic event, and in many cancer patients, the 
symptoms of post-traumatic stress disorder are clear ( Moye and Rouse 2014): 
intrusive thoughts, the sense of reliving the traumatic event, avoidance of memories, 
and a state of hyper-arousal and hyper-activity (American Psychiatric Association 
1994). 
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However, data supporting the presence and the importance of a posttraumatic 
growth in cancer are controversial: while a recent prospective study on 60 head and 
neck cancer patients indicated that baseline levels of PTG decreased significantly 
within a year, and no correlation was shown between PTG and depression and 
anxiety (Leong Abdullah 2015); a systematic review (Kolokotroni et al. 2014) 
appeared to confirm the validity of the conceptual bases of PTG as formulated by 
Tedeschi and Calhoun (1998) for cancer patients. 
 
Considerations 
In this chapter the different declinations of existential distress in patients with 
advanced illness have been focused and the substantial lack of a generally accepted 
definition of this term and construct has been accounted for as well as the absence 
of a universal, clear-cut, comprehensive system of categorization of existential 
suffering (Kleinman 1988; Kissane 2012). Furthermore, it has been highlighted how 
although the frequently employed categorization in physical, psychological, social 
and existential suffering (Kissane 2012; Wilson et al. 2007a; Boston et al. 2011; 
Block et al. 2001; Strang et al. 2004) might suggest that existential suffering is a 
separate entity, however physical, psychological and social suffering may result in 
existential distress, and existential distress may be part of various categories of 
suffering (Morita et al. 2004). 
For this reason the different clinical manifestation typically occurring in advanced 
stages of cancer, overlapping or contributing to existential uffering should be 
always taken into consideration, assessed and treated in the care of these patients. 
Over the years, a number of psychological interventions have been developed with 
the aim to address such dimensions. 
The following chapter will illustrate interventions specifically directed at alleviating 
existential distress in patients with an advanced disease, with a particular focus on 
the ones rooted in existentialism and in existential psychotherapy, whose deepest 
common feature is the consideration of individual as a self-determining agent with 
personal responsibility for authenticity and meaning in life (Craig 2005). 
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Chapter II 
END OF LIFE PSYCHOTHERAPIES: 
FROM THE HUMAN IMPOSSIBILITY TO 
CONCEIVE DEATH TO THE MAN’S SEARCH FOR 
MEANING 
As soon as an individual wakes 
he does not merely want to live out the 
day, but wants to live for something in 
his life (Karl Jaspers 1963) 
 
In the last decades, a number of manualized interventions aimed at treating 
existential distress in patients with advanced disease have thriven. These include 
Supportive-Expressive Group Therapy (SEGT) (Spiegel and Spira 1991), the 
Healing Journey (Cunningham 2002), the Life Threatening Illness Supportive-
Affective Group Experience (LTI-SAGE) (Miller et al. 2005), Family Focused Grief 
Therapy (Kissane et al. 2003) Cognitive Existential Group Therapy (CEGT) 
(Kissane et al. 2003; 2004). 
In the present work, we will focus on the family of interventions referred to as 
“Meaning-centered psychotherapies”, which draw upon shared philosophic bases 
inquiring the issue of meaning in individuals’ life and that will be the object of an 
in-depth analysis in the next sections. 
These interventions include: Meaning Centered Group Psychotherapy (Breitbart 
2002), Meaning Making Intervention (MMI) (Lee et al. 2006), Dignity Therapy 
(Chochinov et al. 2005), and CaLM therapy (Nissim et al. 2012). Table 2.1 shows 
the constitutive aspects common to all meaning-centered interventions. 
Meaning approaches appear particularly interesting for the multifaceted features of 
existential distress they take into account in the treatment of advanced cancer 
patients, and for the inspiring principle that all stages of life can be creative source 
of meaning for the person, even in the face of death. A recent meta-analysis (Vos et 
al. 2015) on a total of 1,792 patients, comparing different types of existential 
therapy, showed that, in the studies examined, meaning centered approaches 
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resulted more effective than supportive-expressive, cognitive existential and 
experiential-existential psychotherapies in almost all the outcomes explored. In 
particular, they evidenced large effects on positive meaning in life, while had 
moderate effects on depression, anxiety and self-efficacy; instead they did not have 
significant effects on self-reported physical well-being. 
 
Mortality in the history of psychotherapy: an unconceivable threat or a source 
of meaning? 
The shared philosophy constituting the foundation of these meaning approaches 
lays in the observation that the dramatic alteration in the life course of individuals 
who are facing a serious existential threat may also inspire a search for meaning, 
resulting in unique opportunities for emotional growth. In this light, the condition of 
suffering and disability and the shadow of mortality may exalt the meaning and the 
poignancy of the present experience and promote a profound positive change even 
at the end of life. 
This process may be seen as mirroring Stern’s (2004) observation that change in the 
psychoanalytic setting tends to occur when the intersubjective field is challenged 
and a renegotiation of the preexisting relationship becomes possible. Similarly, 
serious illness or a terminal condition, with the potentiality of stimulating major 
existential issues in the individual, can offer a unique opportunity for a meaningful 
engagement and a constructive transformation (Rodin and Zimmerman 2008).  
Despite the opportunity of emotional growth offered to receptive individuals by the 
condition of reflecting about death, this area has been often overlooked in 
psychotherapy, to the point that even the otherwise prolific psychoanalytic thinking 
has had a minimal influence on this ambit. Yalom (1980) and Rodin and 
Zimmerman (2008) identified the reason for this phenomenon in the fact that – 
historically - psychoanalytic approaches have sustained the universal human need to 
deny death. According to these authors this view has derived to a large extent from 
a conflict–based metapsychology and from the analysis of physically healthy 
patients who suffered from death anxiety. Thus psychoanalytic position was for 
some time oriented toward the idea described by Freud in his paper Thoughts for the 
Times on War and Death, that it is “impossible to imagine our own death” and that 
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the unconscious senses itself as immortal because it “knows nothing that is 
negative… For that reason it does not know its own death, for to that we can only 
give negative content” (Freud 1957). 
Currently, however, this concept sustaining the intolerability of death awareness is 
being challenged by a growing evidence that nowadays the seriously ill and their 
families tend to prefer honest and open communication of diagnosis and prognosis 
and frank preparation for the end of life (Kirk et al. 2004). This social and cultural 
milieu, which incentivized in the last three decades a profound transformation in the 
doctor-patient relationship, has lead to the development of a different 
psychotherapeutic approach to the dying, whose theoretical bases are to be found in 
existential philosophy and existential psychotherapies. 
 
Existentialism: the core concepts inspiring the search for meaning in 
psychotherapy 
To fully understand the meaning-centered approaches, an examination of the 
philosophic humus in which they are rooted is essential. 
Existentialism is a philosophical current developed by nineteenth and twentieth 
century European philosophers, especially Friedrich Nietzsche, Martin Heidegger, 
Karl Jaspers and Jean-Paul Sartre, who sustained the conception of the individual as 
a self-determining agent with personal responsibility for authenticity and meaning 
in life. 
Friedrich Nietzsche introduced for the first time the important existential themes of 
freedom, choice, responsibility and courage. He also stressed the importance of 
personal meaning to guide life, enclosed in his famous statement “he who has a 
‘why’ to live can bear almost any how” (1888). 
Later on, in 1927, Martin Heidegger formulated in his work Being and Time the 
important theory that the awareness of our personal death acts as a stimulus to adopt 
a higher mode of existence. Heidegger believed that there are two possible ways of 
existing in the world: a state of forgetfulness of being and a state of mindfulness of 
being. Living in a state of forgetfulness of being means being immersed in everyday 
world; while in the state of mindfulness of being, the individual is continually aware 
of being and mindful of his/her own responsibility for being. Since only in this 
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ontological mode the person is conscious of one’s self agency, only here he/she can 
comprehend the power to change him/herself. 
From the start of the 20th century some psychotherapists got inspired by 
phenomenology and existentialism and its possibilities for working with patients. 
Otto Rank, an Austrian psychoanalyst who distanced himself from Freud in the mid-
1920s, is considered the first existential therapist. Ludwig Binswanger, in 
Switzerland, also brought existential insights to his work with patients, in the 
Kreuzlingen sanatorium where he worked as a psychiatrist. Rollo May’s writings 
(1983) kept the existential influence alive in America, contributing to a specific 
conceptualization of therapy (Yalom 1980). Moreover these concepts ended up with 
influencing humanistic psychology to a large extent. 
In Europe, after Otto Rank, Medard Boss developed a method of existential analysis 
in close co-operation with Heidegger. In France the ideas of Sartre, Merleau-Ponty 
and Minkowski, were of great significance. 
In Austria, Viktor Frankl developed an existential therapy called logotherapy, which 
focused particularly on finding meaning. According to Frankl (1963), the leading 
principle guiding individual’s existence was no more the pleasure principle, as 
Freud had maintained, but the meaning principle. Frankl’s approach is considered 
the method of the Third School of Wien (after Freud’s and Adler’s). 
 
Viktor Frankl: the precursor of Meaning Centered Psychotherapies 
As mentioned above, Viktor Frankl believed that it is meaning that most drives man 
and differentiate human beings from other forms of life. Meditating on what he 
defined as an “existential vacuum” he came to the conclusion that “life holds a 
meaning for each and every individual, and even more, it retains this meaning 
literally to his last breath.” In his view, pain and suffering can be changed into a 
personal achievement, as – in his words - “Whenever one is confronted with an 
inescapable, unavoidable situation… e.g., an incurable disease… just then is one 
given a last chance to actualize the highest value, to fulfill the deepest meaning” 
(Frankl 2000). 
Frankl survived the holocaust and the reclusion in four concentration camps, 
including Auschwitz. In this tragic event of his life, during which he lost all his 
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family, he noted that he was “witness to the unexpected extent to which” one 
“remains capable of resisting and braving even the worst conditions” (Frankl 1988). 
This capacity to find meaning for himself and for others made him draw the 
conviction that even in extreme physical and mental suffering there is a possibility 
to resist and to find inspiration and accomplishment in life. 
In Frankl’s view the individual who does not feel “meaningful”, searches a 
compensation in artificial sources of gratification (such as drugs or other forms of 
addiction) or in destroying or self-destroying attitudes which give him an illusion of 
being in power. This is why the contemporary man – already sexually liberated – 
feels profoundly frustrated in his system of values: this position differentiates the 
focus of logotherapy, which lays in meaning, from the original focus of 
psychoanalytic metapsychology, based on the theory of impulses. 
Frankl firmly believed that as a psychotherapist he had the task to show patients that 
life never ceases to have a meaning, under any conditions. He also postulated that 
nobody can tell another what the meaning is, as it is subjectively defined and can 
only be found through a personal process. He had in mind that even the tragic 
aspects of existence, such as unavoidable suffering, can be turned into a fulfillment 
by the attitude which a man adopts toward life and himself. 
In Man's Search for Meaning (1984), Frankl offers an important perspective 
with which to approach the terminally ill. He wrote: “In spite of all the enforced 
physical and mental primitiveness of the life in the concentration camp, it was 
possible for spiritual life to deepen. Sensitive people who were used to a rich 
intellectual life may have suffered much pain… but the damage done to their inner 
selves was less”. 
Frankl refers to a spiritual freedom -which cannot be expropriated- that can preserve 
dignity and vitality even in the hardest circumstances. 
As mentioned before, Frankl can be rightly considered the precursor of all therapies 
whose aim is to help the patients in an advanced state of illness find meaning and 
purpose in the face of their dramatic condition, through the promotion of a sense of 
responsibility and engagement with life. 
In the next sections an overview of the three main meaning centered approaches 
will be given, namely Meaning-Centered Group Psychotherapy, Dignity Therapy 
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and Managing Cancer and Living Meaningfully (CaLM) therapy, with particular 
attention to the last one, which is the object of the present research. 
 
Table 2.1 - Constitutive aspects of meaning-centered interventions 
Shared core concepts Common features 
Attribution of meaning to the terminal phase of life Brevity 
Promotion of self-agency and engagement in life Flexibility 
Legacy (how to leave a trace of oneself) Modularity 
 
Meaning-Centered Group Psychotherapy 
Meaning Centered Psychotherapy (MCGP) has been developed by William 
Breitbart (2002) and is aimed at providing spiritual support tool to patients who face 
a terminal disease. 
In the course of this group therapy the therapist is called to have in mind and make 
constant references to the key concepts of the existentialist thought. The concept of 
spirituality is, in line with the existentialist postulates, different from the one of 
"religiosity" and is conceived in its broader significance, connected to the need of 
sources of meaning and purpose present in every human being. Breitbart relates 
patients’ existential distress and the possible desire for a hastened death to profound 
feelings of demoralization, anxiety, fear and hopelessness that arise when life is no 
longer given meaning and value. Through the reading of Frankl’s writings, MCGT 
incentivizes and guides the experiential work with patients. The concept of life 
finiteness, linked to the disease, is used in this perspective to promote the work of 
identifying the existential values that allow the patient to grasp a personal sense of 
wholeness, meaning, coherence and legacy. The concept of legacy plays a 
particularly important role and is seen as building a sense of continuity between the 
life lived, the life that is being lived and the messages and traces the patient hopes to 
leave. The aim is to create a bridge connecting past, present and future. The format 
of sessions is closed and consists of 8 meetings of 90 minutes which take place on a 
weekly basis. The therapist makes every attempt to find out the sources of meaning 
through which the patient’s history can be explored, by focusing on the use of 
empathy to create a co-construction of meaning (Breitbart 2002). Participants are 
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encouraged to compare their experiences. Between sessions, exercises and 
homework are offered in order to stimulate creativity and the construction of a 
legacy project that represents the culmination of the therapeutic process. The focus 
of therapeutic work is aimed to emphasize that, when facing events that transcend 
the person’s choice, the remaining freedom is how one chooses to live these events 
and this is the only possibility to transcend the limits of life. Exercises are offered 
that lead the way in which participants would like to be remembered. 
The meaning-centered psychotherapy has revealed effective in improving quality of 
life, spiritual well-being, feelings of hopelessness and generally the coping style of 
patients with advanced and terminal cancer (Breitbart et al. 2010). The therapeutic 
strategy is identified with the expansion of the range of possible sources of meaning 
through the combination of theoretical elements on the philosophy of meaning on 
which this intervention is based, and group exercises and homework that each 
participant can do and freely discuss, with possible interpretative comments by the 
therapist. The limited time structure makes this method particularly suitable for use 
in hospitals. In 2012 Breitbart and Collegues developed an individual meaning 
centered psychotherapy, by adapting the group therapy frame to an individual 
intervention, while maintaining the crucial aspects of structure and themes 
addressed. 
 
Dignity Therapy 
The Dignity Therapy has been developed by Harvey Chochinov (2005) to meet the 
existential needs of terminal patients in palliative care. It’s focus relies on a theme 
of great importance in the process of medicine humanization, that in fact is dignity. 
In recent years as a results of the hyper-specialization and technologic 
transformation of medicine, the theme of dignity has had the purpose of defining the 
ethical limits of many medical practices, and the need not to lose sight of the person 
as an entirety. Understandably the issue of dignity is a particularly complex one in 
the context of end of life care. One controversial theme linked to this issues is the 
desire for a hastened death, that dying patients can express when they experience 
the latter part of their life as meaningless, unbearable and no more worth living. 
Hack and colleagues approach this issue by analyzing the concept of dignity from 
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the patients’ point of view, and coming to the conclusion that the deepest reason for 
the loss of dignity experienced by patients in a state of terminal illness, is linked to 
feelings of dependency and demoralization. These results outline that palliative care 
professional are not only called to provide management of physical symptoms and 
pain but that addressing existential distress and supporting hope should be as well 
taken into consideration (Chochinov 2006). In this perspective Chochinov 
elaborated a method of therapeutic support centered on the issues of dignity 
(Chochinov et al. 2005).
 
In Chochinov’s conception, dignity is profoundly relates to 
the theme of generativity, i.e. the awareness of how some patients’ dignity is linked 
to the feeling that their life has had a reason. 
A further aim of this intervention is the maintenance of sense of self and identity in 
the face of the disease progression; the therapist works on this issue by encouraging 
the person to disclose and describe the central aspects of his/her personality. 
Maintenance of roles is another crucial theme, often concerning the possibility to 
still feel like a mother or a father. During the meetings, the therapist uses questions 
to help the patients recognize and maintain a sense of identification with the role 
played in their lives. Pride is protected and encouraged by giving the patient the 
opportunity to talk about achievements he/she considers important. Hope is 
supported by the encouragement to maintain a sense of purpose of life and by 
attributing meaning to life that has been lived and life that is being lived. Finally, 
the standards of care and the communication with healthcare providers are 
discussed to identify any issues that can interfere with the maintenance of dignity.  
Dignity Therapy has a narrative structure. During the encounters the therapist 
addresses the themes of dignity also by asking a series of coded questions, such as: 
"tell me a little of your personal history, the things you remember best, which do 
you think are most important?". Or "what would you like your family to know about 
you, are there things that you would like to be remembered for?” (Chochinov 2006). 
The intervention is composed by four individual sessions which take place at the 
bedside of patients, either in hospital or at home. Sessions are recorded and then 
transcribed. In the last encounter the therapist reads the manuscript of the sessions 
to the patient; this is an emotionally involving moment and gives the therapist the 
possibility to make corrections before the final document is completed and 
23 
delivered to the patient or to whom the patient has identified for this purpose. The 
aim is to draw up a document which represents the "legacy" of the person, 
something meaningful that will survive, thus helping to restore a sense of meaning, 
value and dignity. 
 
Managing Cancer and Living Meaningfully (CaLM) Therapy 
Gary Rodin and Collegues (Nissim 2012), in reflecting upon the unique condition 
faced by patients with a life-threatening illness, described it as one of “double 
awareness” of engaging with life while facing one's imminent death. 
From this point of view, in designing CaLM therapy they considered the specific 
factors facilitating the psychotherapeutic process in the seriously ill as intimately 
linked to: 
 increased help-seeking and reflective functioning; 
 heightened need for authenticity; and 
 increased motivation and sense of urgency to address interpersonal and 
existential issues. 
However, they also observed that themes emerging in delivering psychotherapy to 
patients suffering from advanced and life-threatening disease can be multiple and 
may contemporarily include practical issues of disease and symptom management, 
the confrontation with social and relational changes, along with spiritual and 
existential and mortality-related preoccupations. 
Keeping these issues in mind the authors’ commitment was to manualize a brief 
individual psychotherapy specifically developed to address these concerns, which 
had the potential to mitigate depressive symptoms and other aspects of distress 
while fostering a psychological growth in this population. 
The intervention that resulted from this effort -CaLM therapy- has its foundations in 
several theoretical traditions, including relational theory, attachment theory, and 
existential psychotherapy. 
Relational theory, informed by interpersonal psychoanalysis, the British school of 
object-relations theories, and self psychology, focuses on the dialectical nature of 
the therapeutic situation wherein patient and therapist co-create meaning and 
understanding of the patient’s experience (Mitchell 1988). 
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Attachment theory (Bowlby 1982), outlines that early relationships with primary 
caregivers form enduring internal working models that remain stable and persistent 
patterns of cognition, emotion and behavior in important relationships throughout 
life. Attachment security, though, along with the inclination of individuals to believe 
they are worthy of care and that others are trustworthy to provide it, may be 
threatened by the experience of being seriously ill and psychotherapy may be able 
to enhance positive attachment and facilitate adjustment to the radical alterations in 
attachment needs. 
Existential psychotherapy (Yalom 1980), rooted in the analytic tradition and 
humanist psychology - as fully described above – focuses on the conflict arising 
when individuals confront the givens of existence: death, freedom, isolation, and 
meaninglessness. 
Struggling with mortality takes these conflicts to the extreme and psychotherapy 
should be directed at helping the person manage and tolerate the existential 
suffering brought about by this confrontation and encourage the potential 
psychological growth which can originate from this experience. 
In addition to these theoretical bases, CaLM draws upon several manualized 
psychotherapeutic interventions recently developed to address distress in patients 
with advanced illness. These include Supportive-expressive group therapy (Spiegel 
et al. 1981; Spiegel et al. 1999; Classen et al. 2001; Goodwin et al. 2001; Giese-
Davis et al. 2002; Bordeleau et al. 2003; Weiss et al. 2003), Cognitive-Existential 
Group Therapy (Kissane et al. 2003; Kissane et al. 2004), and especially Meaning 
Centred Group Psychotherapy (Breitbart et al. 2004) and Dignity Therapy 
(Chochinov et al. 2005). 
The CaLM intervention is intended to complement rather than reproduce these 
approaches. It is in fact designed as an individual therapy aimed at addressing the 
practical, relational and existential domains of experience, regardless of their level 
of death acceptance or readiness for death preparation. 
The primary goals of this intervention are therefore the reduction of 
psychological/existential suffering and the prevention of future distress. 
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However, although the symptomatic alleviation of distress is an important goal of 
psychotherapeutic treatment, it seem too limited a purpose when considering the 
potential effects psychotherapy may produce. 
Indeed, in spite of the fact that the potential for continued psychological growth and 
development at the end of life was not took in consideration by the early psychiatric 
and psychoanalytic literature, recent research suggested that the final life stage 
brings with it unique possibilities for individual development, and documented the 
potential for psychological growth following trauma, including that associated with 
cancer and other life-threatening illnesses (Sumalla et al. 2009). 
In this perspective, CaLM therapists are required to feel comfortable with the 
existential issues confronted by their patients. The authors believe that awareness of 
their own sense of meaning and purpose, and challenges in the face of mortality will 
help therapists to “bracket out” their feelings and beliefs and keep focus on the 
patient’s experience. 
The treatment and engagement with patients, however may also elicit distressing 
reactions in the therapist which need to be understood and managed. Supervision 
and peer-support, is therefore recommended in CaLM therapy. 
In its original format, CaLM therapy consists of 6 individual psychotherapy 
sessions of 45 minutes delivered on a monthly basis. Session are generally frontal, 
but, if required for reason concerning the patient’s health conditions, it is possible to 
have telephonic sessions.  
The general themes that should be addressed with 
all patients at some point during the intervention have been conceptualized in four 
modules: 
1) Symptom Management and Communication with Health Care Providers 
2) Changes in Self and Relations with Close Others 
3) Spirituality or Sense of Meaning and Purpose 
4) Thinking of the Future, Hope and Mortality 
These modules are not meant necessarily to receive equal time and attention, 
instead, they are designed as a “framework” for the therapists to keep in mind, 
although the ultimate goal is to “stay with the patient” in terms of the issues and 
concerns that they generate as most important. The module themes – in fact - are 
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profoundly intertwined, and therapists should feel free to move between them as the 
patient see fit. 
An initial patient interview is directed at exploring each of these areas with the aim 
of delivering an individualized approach, with focus on the most problematic areas. 
The intervention is best delivered in the context of a multimodal approach to patient 
care, where adequate attention is also given to pain and symptom relief, family 
distress, planning for end of life care, and psychopharmacological treatment when 
required. 
The therapeutic elements can be summarized as follows: 
 Supportive Relationship 
 Authenticity 
 Modulating affect 
 Encouraging Reflective Functioning 
 Renegotiation of attachment Security 
 The Joint Creation of Meaning 
 Shifting Frame and Flexibility 
 Facing the Limits and Boundaries 
  Interpretation 
 Termination 
By examining these elements, it is possible to conclude that the CaLM process lays 
in the attitudes and principles of a profoundly collaborative, respectful and authentic 
therapeutic position which, in combination with the content themes of its four 
modules constitute the “philosophy” of CaLM. 
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Chapter III 
THE RESEARCH 
 
The aims of the study 
The experimental part of the present work was aimed to perform, in an Italian 
context, a randomized controlled trial on a psychological intervention designed for 
patients with advanced cancer, referred to as Managing Cancer and living 
meaningfully (CaLM) which has been found in preliminarily research to have 
substantial benefits for patients with advanced cancer (Nissim et al. 2012; Lo et al. 
2014). 
As fully illustrated in the previous chapter, this approach is meant to address the 
practical, relational and existential dimensions of the illness experience, through 
providing support and offering the opportunity to reflect and process thoughts and 
emotions evoked by the disease and its consequences. Although CaLM is an 
individual therapy, participation of the designated primary caregiver in at least one 
session is encouraged, with the purpose of allowing for more effective assessment 
and enhancement of family adjustment. 
The research specific objectives were: 
 assessing the feasibility and acceptability of the proposed approach in an 
Italian context where concepts including sense of meaning, spirituality, 
existential growth and attachment might entail connotations different from 
the original culture where it has been developed; 
 exploring CaLM efficacy in alleviating depression and demoralization as 
compared to non psychological treatment (usual care); 
 testing CaLM efficacy in improving other aspects of existential distress, 
including generalized anxiety and death anxiety; 
 measuring psychological growth, satisfaction with care, spiritual well-being 
and quality of life as a result of this psychotherapeutic intervention; 
 evaluating the existence of an influence of post-traumatic growth promoted 
by psychotherapy on patients’ symptoms and on spiritual wellbeing; 
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 examining the subjective experience of receiving this specific individual 
psychological intervention. 
By carrying out the present study, therefore, the expected primary outcomes were 
that this tailored individual psychological intervention would result feasible and 
acceptable for Italian patients and would produce a greater reduction in depression 
and demoralization symptoms than usual care. Secondarily we hypothesized that 
this intervention would ameliorate other symptoms of distress, while generating a 
better spiritual well-being and quality of life, more personal growth and greater 
satisfaction with care than the untreated population. Furthermore we expected that – 
given the angle of this approach, specifically aimed at promoting the sense of 
meaning, awareness and emotional growth of the individual – improvements would 
result to a large extent from an experience of post-traumatic growth. 
 
Materials and methods 
The study has been carried out in the Department of Biomedical and Specialty 
Surgical Sciences of the University of Ferrara. The psychotherapeutic interventions 
were performed and supervised respectively by the Researcher (R.C.) and 
Supervisor (L.G.) directly trained in CaLM by the Authors who developed it at the 
Princess Margareth Cancer Center in Toronto. Furthermore, peer supervisions with 
other professionals who were receiving a training in CaLM assured a shared 
experience. 
Experimental group participants received CaLM intervention designed for advanced 
cancer patients. Control participants received usual care. 
CaLM: Participants in the experimental group received a semi-structured 
psychological intervention embedded within a collaborative care system of case 
identification, treatment and follow-up. In this Italian adaptation, CaLM was 
composed by 12 individual sessions (45-60 minutes each), rather than 6 sessions, 
delivered over 6 months on a 15 day basis and no possibility of telephonic session 
was considered. Sessions were audio-recorded to ensure treatment fidelity. The 
encounters covered the four CALM domains: 1) symptom management and 
communication with health care providers; 2) changes in self and relations with 
close others; 3) spiritual well-being, sense of meaning and purpose; and 4) 
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preparing for the future, sustaining hope and facing mortality. All domains were 
addressed with each patient, but the time devoted to each module varied, based on 
the concerns most relevant to that particular patient. The participant's caregiver was 
offered to participate in one or more of the sessions, as deemed appropriate by the 
therapist. 
At any time during the intervention, patients deemed at acute risk for suicide, who 
would demonstrate significant worsening of depression, or would require treatment 
for other psychiatric co-morbidities, based on the clinical judgment of the therapists, 
would have been referred for psychiatric assessment and treatment, including 
possible pharmacotherapy. 
USUAL CARE. Usual care (UC) includes oncology clinic visits, and a psychiatric 
and psychopharmacologic management. 
 
Inclusion and exclusion criteria 
Patients referred to Psycho-oncology service who met the inclusion criteria were 
offered to take part in the study on a voluntary basis. 
Inclusion criteria were: 1) >=18 years of age; 2) fluency in Italian language; 3) no 
cognitive impairment; 4) confirmed or working diagnosis of “wet” stage IIIB (those 
not treated with curative intent) or IV lung cancer, any stage of pancreatic or other 
stage IV GI cancer, stage III or IV ovarian and fallopian tube cancers, or other stage 
IV gynecological cancer; and stage IV breast, genitourinary, sarcoma, melanoma or 
endocrine cancers (expected survival of 12-18 months); a score ≥ 10 at PHQ9 or ≥ 
20 at DADDS. 
Exclusion criteria were: 1) communication difficulties; 2) inability to commit to the 
required 3-6 sessions (i.e., too ill to participate, lack of transportation, etc.); 3) a 
score <20 on the Short Orientation-Memory-Concentration (SOMC) (Katzman R et 
al. 1983) test, indicating cognitive impairment unless deemed suitable at recruiter's 
discretion; 4) actively seeing a psychotherapist, and 5) lack of reported distress. 
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Outcome Measures 
All measures (with the exception of the CEQ-UC and CEQ-CaLM, which were not 
administered at baseline) were completed by participants at baseline, at 3 (T1) and 6 
(T2) months of treatment. 
The primary outcome measures of the study were the Patient Health Questionnaire-
9 (PHQ-9) (Kroenke et al. 2001) and the Demoralization Scale (DS) (Kissane et al. 
2004). PHQ-9 is a 9-item measure of depression. Two additional items assessing 
intent to cause self-harm and rating how difficult these symptoms have made it to 
do work, take care of things at home, or get along with other people, have been 
included. 
The Demoralization scale is a 24-item self-report measure assessing existential 
distress in terms of loss of meaning and purpose, disheartenment and helplessness. 
By using secondary outcome measures, domains likely to respond directly to the 
intervention or indirectly were assessed, through CaLM potential impact on 
communication with health care providers. A portion of the Mood Disorders and 
Optional Disorders Module of the Structured Clinical Interview for DSM Disorders 
(SCID) (First et al. 2010) was administered at all data collection points. The SCID 
complemented the PHQ-9, and allowed us to make the diagnosis of Major 
Depressive Episode and Minor Depressive Disorder. The Generalized Anxiety 
Disorders-7 (GAD-7) (Spitzer et al. 2006) is a 7-item self-report measure designed 
to screen the severity of GAD symptoms. An eighth item rating how difficult these 
symptoms have made it to do work, take care of things at home, or get along with 
other people, has been included. The Functional Assessment of Chronic Illness 
Therapy-Spiritual Well-Being Scale (FACIT-Sp) (Peterman et al. 2002) is a 12-item 
self-report measure of spiritual well-being, was administered, in order to assess 
patients’ sense of meaning, peace and faith. The Posttraumatic Growth Inventory 
(PTGI) (Tedeschi and Calhoun 1996) is a 21-item self-report scale that measures 
positive psychological changes after trauma. The Quality of Life at the End of Life-
Cancer Scale (QUAL-EC) (Lo et al. 2010) is a measure of quality of life in patients 
near the end of life. We did not included the symptom control subscale. 
Furthermore we assessed death anxiety using the 15-item Death and Dying Distress 
Scale (DADDS), recently developed for use in advanced cancer (Lo et al. 2011). We 
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also assessed attachment security using The Experiences in Close Relationships 
Inventory Modified Short Form Version (ECR-M-16), a 16-item self-report measure 
of the attachment style (i.e. style in relationships perceived to be important for felt 
security), yielding scores on two dimensions: avoidance and anxiety (Lo et al. 
2009). 
Disease symptom severity was collected using a shortened version of the Memorial 
Symptom Assessment Scale (MSAS) (Portenoy et al. 1994). It measured the 
presence and severity of 28 common physical symptoms of cancer. Participants who 
are married, common-law, or in a long-term relationship were asked to complete the 
Couple Communication Scale (CCS) (Olson and Larson 2008) taken from the 
PREPARE/ENRICH Inventory. Intervention and control participants completed 
respectively CEQ-CaLM and CEQ-UC Questionnaire at 3- and 6-months; it 
assessed the level of mastery and insight patients have gained in time. 
Demographics, medical and psychiatric history, and performance status data 
(Karnofsky Performance Status Scale) (Karnofsky and Burchenal 1949), were also 
collected. 
 
Results 
Statistical analysis has been carried out by using 
 
Sociodemographics 
A total of 50 patients addressed to the Psycho-Oncology Service and meeting the 
inclusion criteria initially volunteered to participate in the study. The total sample 
were composed by 38 (76%) women and 12 (24%) men. The mean age was 60 
years (SD±11.8). Cancer sites were represented as follows: breast = 40%; colorectal 
= 16%; prostate = 12%; lung = 10%; gastric = 4%; brain = 4%; ovary = 6%; 
pancreas = 2%; kidney = 4%; other = 2%. The mean years of education were 13.2 
(SD±2.8). Of these patients, 27 were randomized to be allocated in the CaLM group 
and 23 in the UC.  
The number of subjects who completed at least phase T1 was respectively 18 in 
CaLM group and 19 in UC. Table 3.1 illustrates the drop-out frequencies and 
motivations. 
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Marital status, working conditions and possible psychopharmacologic therapies of 
subjects who completed at least T1 assessment are illustrated in tables 3.2-3.4. 
 
Data Analysis 
Analysis of data obtained from patients who completed at least 3 month (T1) 
intervention are now presented. Statistical analyses have been performed by using 
SPSS Statistics program. 
 
Primary outcomes - Depression and Demoralization 
A significant improvement of PHQ9 was observed in the experimental group, 
between phases T0 (mean 13.33; SD±5.34) and T1 (mean 8.38; SD±4.38) (p 0.00) 
and T0 and T2 (mean 7.56; SD±4.50) (p 0.01); while in the UC group, even if a 
trend of PHQ9 worsening was observed, no statistically significant change 
occurred. 
As far as Demoralization Scale is concerned, a statistically significant decreasing 
was produced in Loss of Meaning between T0 (mean 4.50; SD±3.62) and T1 (mean 
2.30 SD±2.89) (p 0.01); Disheartenment between T0 (mean 2.0; SD±1.32) and T2 
(mean 1.1; SD±1.16) (p 0.05), Helplessness between T0 (mean 6.80 SD±2.93) and 
T1 (mean 3.80 SD±3.93) (p 0.03) and Sense of Failure between T1 (mean 3; 
SD±1,87) and T2 (mean 1.67; SD±1.73) (p 0.02) subscales. No significant changes 
were noticed in the UC group, although, again, a trend of general worsening was 
observable. 
 
Secondary outcomes 
Post-traumatic Growth: The CaLM Group showed a significant improvement in the 
following PTGI subscales: PTGI Compassion, between T0 (mean 5.38; SD ±2.98 ) 
and T1 (mean 7.00; SD ±1.82) (p 0.06); PTGI New Possibilities, between T0 (mean 
10.81 SD±2.22) and T1 (mean 15.00 SD±3.84) (p 0.02); PTGI Spiritual Change, 
between T0 (mean 7.54 SD ±2.69) and T2 (mean 9.54 SD ±3.07) (p 0.01). No 
significant changes were detected in UC group. 
Spirituality: A better spiritual well-being was documented in the experimental 
group, in the subscales Inner Peace, between T1 (mean 10.30; SD±3.42) and T2 
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(mean 12.63; SD±4.10) (p 0.03); Faith and Spirituality between T0 (mean 5.00; 
SD±3.83) and T1 (mean 7.00; SD±4.87) (p 0.01) and Meaning and Purpose between 
T0 (mean 10.36; SD±4.56) and T1 (mean 12.00; SD±3.46) (p 0.02), and between 
T0 (mean 11.22; SD±4.63) and T2 (mean 13.33; SD±3.31) (p 0.02).  
UC group reported no statistically significant change. 
Anxiety: No statistically significant change have been noticed in patients’ death 
anxiety, as measured by DADDS. However a trend of, respectively, reduction and 
worsening, has been observed in CaLM and control group. 
A significant reduction of general anxiety as measured by the GAD-7 scale, was 
instead evidenced between T0 (mean 8.83 SD±5.68) and T1 (mean 6.00; SD±4.91) 
(p 0.03) only in the experimental group. 
Quality of life: no statistically significant result has been obtained using QUAL.EC 
scale.  
Satisfaction with care: CaLM patients showed a greater satisfaction with care than 
UC ones. Average scores at CEQ questionnaire were 19.33±8.22 (T1) and 26.43± 
1.71 (T2) for CaLM patients and 14.36±9.90 (T1) and 15.75±7.90 (T2) for UC 
group. 
Experimental group patients’ satisfaction, moreover, have been further confirmed by 
the tenor of comments patients have been invited to share in a written form after 
completing CEQ questionnaire.  
Some of these comments are reported below: 
• “Coming here helped me think of what is important to me in this very 
moment: people with cancer can have things out of hospital that are 
important too” 
• “ My wife convinced me to ask for help. Before cancer I used to think that 
men never do, but now here I am. I don’t know whether I’m going to get 
better or not, but coming sometimes is good for my mind and soul” 
• “When you are suffering you feel alone with your pain. Then you see how to 
share it with others…” 
• “It has been a difficult, interesting, intense and surprising journey into 
myself”. 
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Relationship between PTGI and Depression and Demoralization 
In order to verify the initial hypothesis that a post-traumatic growth derived from 
this psychotherapeutic approach would influence patients’ symptoms and spiritual 
wellbeing, correlation analyses first and then linear regression analyses have been 
performed. 
The analyses indicated a strong effect of PTGI (Spiritual Change and Relating to the 
Others) on the Dysphoria dimension of Demoralization Scale (Adjusted R square 
0.73; p 0.03); and an effect of PTGI (Personal Strength and Relating to Others) on 
PHQ9 (Adjusted R square 0.42; p 0.03). 
Furthermore, PTGI (Appreciation of Life) showed to influence FACIT (Faith and 
Spirituality) (Adjusted R square 0.43; p 0.03). No relationship have been 
demonstrated in patients who did not receive CaLM therapy (UC group). 
Tables 3.5 – 3.7 illustrates more in detail the results of linear regression tests. 
 
Table 3.1 Motivations of drop out at any time before phase T1 
 Frequency Percent 
Death of patient 3 23.07% 
Voluntary drop-out 2 15.38% 
Worsening of clinical conditions 8 53.84% 
Total 13 100% 
 
Table 3.2 
 Frequency Percent 
Single 1 2.7 
Married/Domestic Partnership 26 70.27 
Divorced 5 13.51 
Widowed 5 13.51 
Total 37 100 
 
 
 
35 
 
 
 
Table 3.3 Working conditions of patients completing at least T1 phase 
 Frequency Percent 
Employee 10 27.0 
Self-employed 5 13.5 
Student 1 2.7 
Housewife 5 13.5 
Retired 15 40.5 
Unemployed 1 2.7 
Total 37 100 
 
Table 3.4 Types and frequencies of prescribed therapies 
 Frequency Percent 
No therapy 15 40.54 
AD 9 24.32 
BDZ 2 5.40 
AD + BDZ 11 29.79 
Total 37 100% 
AD = Antidepressant therapy; BDZ= Benzodiazepine therapy 
 
Table 3.5 – Effect of PTGI (Personal Strenght and Relating to Others) on PHQ9 
CaLM_CONTROL Model Adjusted R Square 
Standard 
Error of the Estimate 
Sig. 
CaLM       1 0.42 3.22 0.03 
Control     1 0.16 6.11 0.19 
 
Table 3.6 – Effect of PTGI (Spirit. Change and Relat. to Others) on Demo Scale (Dysphoria) 
CaLM_CONTROL Model Adjusted R Square 
Standard 
Error of the Estimate 
Sig. 
CaLM       1 0.73 1.14 0.03 
Control     1 -.27 2.82 0.79 
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Table 3.7 – Effect of PTGI (Appreciation of Life) on Facit (Faith and Spirituality) 
CaLM_CONTROL Model Adjusted R Square Standard 
Error of the Estimate 
Sig. 
CaLM       1 0.43 3.85 0.03 
Control     1 0.68 4.09 0.28 
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Chapter IV 
DISCUSSION 
 
Failure to sustain the “double awareness” of engaging with life while facing one's 
imminent death has been demonstrated to increase the risk for existential distress. 
This may complicate the end of life process, potentially anticipating a 
“psychological death” in patients with an advanced disease (Rodin et al. 2007). 
Recent researches highlighted that palliative care intention predicts higher 
depression and higher demoralization in cancer patients (Vehling et al. 2012; 
Mitchell AJ et al. 2011). 
Depression, in particular, represents an important and debilitating facet of 
existential distress and one of the most studied areas in advanced cancer care, since 
it shows prevalence rates of 16% to 25% in this population, compared to an 
approximate rate of 5% in the general population and is related with severe 
individual and interpersonal negative consequences (Mitchell AJ et al. 2011). 
On the other hand, numerous studies outlined that another possible component of 
existential distress, namely demoralization, while presenting some similar features 
to depression, is phenomenologically independent and characterized by 
hopelessness and helplessness feelings, loss of meaning and purpose, feeling of 
being trapped and having failed in facing a stressed situation. Differently from 
depression, demoralization does not present anhedonia, loss of pleasure and interest 
in life activities. 
Demoralization has been found in association with reduction of life quality, higher 
demand of hastened death, and worsening of the prognosis, independently from the 
biological variables (Bordeleau et al. 2003). 
This evidence constitutes the basis for the development of innovative and specific 
interventions aimed at reducing depression and demoralization in advanced cancer 
patients, while promoting meaning making processes and personal growth (Rodin 
and Zimmermann 2008). Although group psychotherapies in this area have been 
proven to alleviate existential distress and are considered more cost-effective, 
individual approaches tend to be preferred by patients and are often more feasible to 
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deliver in subjects with advanced illness, as sessions can be scheduled with 
flexibility, taking into account the particular needs of the individual patient (Clark et 
al. 2003). 
The findings of the present study confirm the full acceptability of Italian patients of 
this innovative approach, as testified by the written comments shared by patients 
about their satisfaction with care and the general consideration that this therapeutic 
process “has made a difference” in their life in terms of perception of self and of 
individual meaning of existence in the face of illness. 
Importantly, the outcomes obtained indicated the efficacy of this intervention in 
alleviating depression, demoralization, anxiety and in improving spiritual well-
being: all aspects which flow into the construct of existential distress, as already 
mentioned in Chapter I (Rousseau 2001; Morita 2004; Kirk et al. 2010; Schuman-
Olivier et al. 2008; Yalom 1980). 
Moreover, several dimensions of post-traumatic growth have been showed to result 
from this approach, namely a higher sense of compassion, a spiritual change and the 
feeling of having new possibilities in life. 
At a deeper analysis, psychological growth derived from psychotherapy appeared to 
have influenced improvements in depression and dysphoria symptoms, as well as 
the achievement of a higher spiritual well-being. This confirms previous literature 
data suggesting that post-traumatic growth can play a role in mitigating depression 
symptoms (Kleim and Ehlers 2009; Park and Fenster 2004; Carver and Antoni 
2004; Mc Millen et al. 1997), as well as promoting more well-being while lessening 
distress and anxiety (Park and Fenster 2004). 
The originality and the relevance of the present study are linked to different aspects. 
The first is represented by the lack of data concerning different dimensions of 
suffering on the spectrum of emotional distress other than depression, in particular 
the Demoralization Syndrome, in patients affected by advanced cancer. This aspect 
is even more evident in non-Anglo-Saxon literature. Yet these are extremely 
important issues in cancer and palliative care and need to be studied in different 
cultural contexts. This study can represent a step forward to a better comprehension 
of how a specific model of care – modulated on the basis of the characteristic of the 
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population it is directed to - can help to assess and manage existential and 
psychosocial issues. 
A second important and innovative aspect is linked to the future possibility to 
further test and apply in Italy this specific intervention model in different clinical 
contexts (eg. cancer outpatient and day-hospital clinics, in-patients units, hospices) 
and different research centers. 
Another relevant possibility for future applications is represented by the opportunity 
of training cancer and palliative healthcare professionals, including nurses, in the 
CaLM general principles, practical approach and outcome measures, in order to 
improve clinician-patient relationship, assessment abilities and management of 
psychosocial aspects of illness, within a perspective of global and integrated care. 
This could contribute to the aim of developing training guidelines, internationally 
shared, on the most appropriate and validated psychological treatment in the 
advanced phases of cancer. 
The main limitation of this work is represented by the short number of patients 
tested: further research is needed in order to expand the sample size and thus obtain 
more accurate data. 
A second limitation which needs to be accounted for is that the study involved only 
patients who were motivated to take part in a psychotherapy process. However, 
although this is understandably a possible cause of bias, as these patients could be 
unrepresentative of the whole advanced cancer patients population, it must be 
pointed out that it is as well an unavoidable limitation common to all the research 
on the psychotherapy area. 
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Chapter V 
CONCLUSIONS 
Nothing in his life 
Became him like the leaving it. 
William Shakespeare. Macbeth, Act I. 
 
The present research demonstrated the feasibility in Italy of CaLM psychotherapy 
for advanced cancer patient. 
The intervention showe effectiveness on reducing existential distress, while 
promoting spiritual well-being and a post-traumatic psychological growth. 
Furthermore, a positive influence of post-traumatic growth on the reduction of 
depressive symptoms and on the achievement of a better spiritual balance was 
indicated. 
These findings highlight that the goals of CaLM are not to be intended as simply 
limited to symptom reduction, but include an enhanced integration of memories, 
emotions and patterns of cognition that enable advanced cancer patients to live 
more meaningful lives, to find a sense of purpose and explore new ways to become 
more effective agents in their existence, even while facing the tragic condition of 
being ill, frail and mortal. 
 
 
 
 
 
 
 
 
 
 
 
 
 
41 
REFERENCES 
 
- American Psychiatric Association. Committee on Nomenclature and Statistics. 
Diagnostic and Statistical Manual of Mental Disorders, Second Edition. 
Washinton DC. 1968. 
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental 
Disorders, Fourth Edition. Washinton, DC. 1994. 
- Armeli S., Gunthert K.C., and Cohen L.H. Stressor appraisals, coping, and 
postevent outcomes: The dimensionality and antecedents of stress-related 
growth. Journal of Social and Clinical Psychology 2001; 20, 366-395. 
- Block S.D. Psychological considerations, growth, and transcendence at the end 
of life. The art of the possible. JAMA 2001; 285:2898–2905. 
- Bordeleau L., Szalai J.P., Ennis M., Leszcz M., Speca M., Sela R., Doll R., 
Chochinov H.M., Navarro M., Arnold A., Pritchard K., Bezjak A., Llewellyn-
Thomas H., Sawka C., and Goodwin P.J. Quality of life in a randomized trial of 
group psychosocial support in metastatic breast cancer: Overall effects of the 
intervention and an exploration of missing data. Journal of Clinical Oncology 
2003; 21(10), 1944-1951. 
- Boston P., Bruce A., Schreiber R. Existential suffering in the palliative care 
setting: an integrated literature review. J Pain Symptom Manage 2011; 41:604–
618. 
- Braun M., Mikulincer M., Rydall A., Walsh A., and Rodin G. Hidden morbidity 
in cancer: Spouse caregivers. Journal of Clinical Oncology 2007; 25, 4829-
4834.  
- Breitbart W. Reframing hope: meaning-centered care for patients near the end 
of life. Interview by Karen S. Heller. J Palliat Med 2003; 6: 979-87. 
42 
- Breitbart W. Spirituality and meaning in supportive care: spirituality an 
meaning centered group psychotherapy interventions in advanced cancer. 
Support Care Cancer 2002; 10: 272-80.  
- Breitbart W.,. Gibson C., Poppito SR,. Berg A. Psychotherapeutic interventions 
at the end of life: a focus on meaning and spirituality. Can J Psychiatry. 2004 
Jun;49(6):366-72.  
- Breitbart W., Poppito S., Rosenfeld B., Vickers A. J., Li Y. et al. Pilot 
randomized controlled trial of individual meaning-centered psychotherapy for  
patients with advanced cancer. Journal of Clinical Oncology 2012; 
20;30(12):1304-9. 
- Breitbart W., Rosenfeld B., Gibson C. et al. Meaning-centered group 
psychotherapy for patients with advanced cancer: a pilot randomized controlled 
trial. Psychooncology 2010; 19: 21-8. 
- Canada A.L., Murphy P.E., Fitchett G., Peterman A.H., and Schover L.R.. A 3-
factor model for the FACIT-Sp. Psychooncology 2008; 17(9): 908–916. 
- Chen M.L., Chang H.K. Physical symptom profiles of depressed and non-
depressed patients with cancer. Palliat Med 2004;18:712-718. 
- Cherny N.I., Radbruch L. and Board of the European Association for Palliative 
Care. European Association for Palliative Care (EAPC) recommended 
framework for the use of sedation in palliative care. Palliative Medicine 2009; 
23(7): 581–593. 
- Chochinov H.M. Dying, dignity and new horizons in palliative end-of-life care. 
CA Cancer J Clin 2006; 56: 84-103. 
- Chochinov H.M. and Breitbart W. (Ed.) Handbook of Psychiatry in Palliative 
Medicine. Second Edition. Oxford. 2009. 
43 
- Chochinov H.M., Hack T., Hassard L.J. Kristjanson S., McClement, and Harlos 
M. Dignity therapy: A novel psychotherapeutic intervention for patients near the 
end of life. Journal of Clinical Oncology 2005; 23(24): 5520–5525. 
- Chochinov H.M., Wilson K.G., Enns M., Lander S. Depression, hopelessness 
and suicidal ideation in the terminally ill. Psychosomatics. July-August 1998; 
39 (4):366-370. 
- Clark M.M., Bostwick J.M., Rummans T.A. Group and individual treatment 
strategies for distress in cancer patients. Mayo Clinic Proceedings 2003; 
78(12),1538-1543. 
- Clarke D.M. Mackinnon A.J. Smith G.C. et al. Dimensions of psychopathology 
in the medically ill: a latent trait analysis. Psychosomatics 2000;41:418-425. 
- Clarke D.M., Mc Leod J.E., Smith G.C. et al. A comparison of psychosocial and 
physical functioning in patients with motor neurone disease and metastatic 
cancer. J Palliative Care 2005;21:173-179. 
- Cordova M., Cunningham L., Carlson C., and Andrykowski M. Posttraumatic 
growth following breast cancer: A controlled comparison study. Health 
Psychology 2001; 20, 176-185. 
- Carver C. S., and Antoni M. H. Finding benefit in breast cancer during the year 
after diagnosis predicts better adjustment 5 to 8 years after diagnosis. Health 
Psychology 2004; 23, 595–598. 
- Craig E. The shorter Routledge encyclopedia of philosophy, 252–260. New 
York:Routledge. 2005. 
- Cunningham A.J. Bringing spirituality into your healing journey. Toronto: Key 
Porter Books Limited. 2002. 
- Davis C., Nolen-Hoeksema S., and Larson J. Making sense of loss and 
benefiting from the experience: Two construals of meaning. Journal of 
Personality and Social Psychology 1998; 75, 561-574. 
44 
- De Figueiredo J. Diagnosing demoralization in consultation psychiatry. 
Psychosomatics 2000; 41: 449-450. 
- De Graeff A., and Dean M. Palliative sedation therapy in the last weeks of life: 
A literature review and recommendations for standards. Journal of Palliative 
Medicine 2007; 10(1): 67–85. 
- Eckersley R.M. Culture, spirituality, religion and health: looking at the big 
picture. MJA 2007; 186: S54–S56. 
- Eckersley R.M. Well and good: morality, meaning and happiness. 2nd ed. 
Melbourne: Text Publishing. 2005. 
- Erikson E.H. Childhood and Society, 2nd ed. New York: Norton. 1963. 
- Evers A.W.M., Kraaimaat F.W., Van Lankveld W., Jongen P.J.H., Jacobs J.W.G., 
and Bijlsma J.W.J. Beyond unfavourable thinking: The Illness Cognition 
Questionnaire for chronic diseases. Journal of Consulting and Clinical 
Psychology 2001; 69, 1026-1036. 
- First M.B. et al. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, 
Research Version, Non-patient Edition. (SCID-I/NP) New York, NY:Biometrics 
Research, New York State Psychiatric Institute. 2010. 
- Frank JD. Psychotherapy: the restoration of morale. Am J Psychiatry 1974; 131: 
271-274. 
- Frankl V. Man’s search for meaning. Boston: Beacon Press. 1963. 
- Frazier P., Tashiro T., Berman M., Steger M. and Long, J. Correlates of levels 
and patterns of positive life changes following sexual assault. Journal of 
Consulting and Clinical Psychology 2004; 72, 19-30. 
- Freud S. Thoughts for the times on war and death. 1957. In: Rodin G. 
Zimmermann C Psychoanalytic reflections on mortality: a reconsideration. J 
Am Acad Psychoanal Dyn Psychiatry 2008 Spring;36(1):181-96. 
45 
- Fredrickson B.L., Tugade M.M., Waugh C.E. and Larkin G.R. What good are 
positive emotions in crises? A prospective study of resilience and emotions 
following the terrorist attacks on the United States on September 11th, 2001. 
Journal of Personality and Social Psychology 2003; 84, 365-376. 
- Grabsch B., Clarke D.M., Love A. et al. Psychological morbidity and quality of 
life in women with advanced breast cancer: a cross-sectional survey. Palliative 
Support Care. 2006;4:47-56. 
- Grassi L., Indelli M., Marzola M., Maestri A., Santini A., Piva E., Boccalon M. 
Depressive symptoms and quality of life in home-care-assisted cancer patients. 
J Pain Symptom Manage. 1996 Nov;12(5):300-7. 
- Green A.I., Austin C.P. Psychopathology of pancreatic cancer. Psychosomatics. 
1993;34:208-221. 
- Greenstein M. The house that’s on fire: Meaning-centered psychotherapy pilot 
group for cancer patients. American Journal of Psychotherapy 2000; 54(4): 
501–511. 
- Greenstein M., and Breitbart W. Cancer and the experience of meaning: A group 
psychotherapy program for people with cancer. American Journal of 
Psychotherapy 2000; 54(4): 486–500. 
- Hack T.F., Chochinov H.M., Hassard T., Kristjanson L.J., McClement S., Harlos 
M. Defining dignity in terminally ill cancer patients: a factor-analytic approach. 
Psychooncology 2004; 13: 700-8. 
- Hauser K., and Walsh D. Palliative sedation: Welcome guidance on a 
controversial issue. Palliative Medicine 2009; 23(7): 577–579. 
- Heidegger M. Being and Time, trans. by John Macquarrie and Edward 
Robinson London: SCM Press. 1962. 
- Henry M., Cohen S.R., Lee V., Sauthier P., Provencher D., Drouin P., Gauthier 
P., Gotlieb W., Lau S., Drummond N., Gilbert L., Stanimir G., Sturgeon J., 
46 
Chasen M., Mitchell J., Huang L.N., Ferland M.K., Mayo N. The Meaning-
Making intervention (MMi) appears to increase meaning in life in advanced 
ovarian cancer: a randomized controlled pilot study. Psychooncology 2010 
Dec;19(12):1340-7. 
- Hudson P.L., Kristjanson L.J., Ashby M., et al. Desire for hastened death in 
patients with advanced disease and the evidence base of clinical guidelines: a 
systematic review. Palliat Med October 2006; 20(7):693-701. 
- Jaspers K. General Psychopathology (Hoenig and M. Hamilton, trans.) 
Chicago: The University of Chicago Press. 1963. 
- Karnofsky D., and Burchenal J.H. The clinical evaluation of chemotherapeutic 
agents in cancer. 1949. In: Macleod C.M. (Ed.), Evaluation of 
Chemotherapeutic Agents (pp.191-205). New York, NY:Columbia University. 
- Katzman R., Brown T., Fuld P., Peck A, Schechter R., Schimmel H. Validation 
of a short Orientation-Memory-Concentration Test of cognitive impairment. 
American Journal of Psychiatry1983; 140, 734-739.  
- Kirk T.W., Mahon M.M, and Palliative Sedation Task Force of the National 
Hospice and Palliative Care Organization Ethics Committee. National Hospice 
and Palliative Care Organization (NHPCO) position statement and commentary 
on the use of palliative sedation in imminently dying terminally ill patients. 
Journal of Pain and Symptom Management 2010; 39(5): 914–923. 
- Kirk P., Kirk I., and Kristjanson L.J. What do patients receiving palliative care 
for cancer and their families want to be told? A Canadian and Australian 
qualitative study. British Medical Journal 2004; 328, 1343. 
- Kissane D.W.: The relief of existential suffering. Arch Intern Med 
2012;172:1501–1505.  
- Kissane D.W., Bloch S., Smith G.C., Miach P., Clarke D.M., Ikin J., Love A., 
Ranieri N., and McKenzie D. Cognitive-existential group psychotherapy for 
47 
women with primary breast cancer: A randomised controlled trial. 
Psychooncology 2003; 12(6): 532–546.  
- Kissane D.W., Love A., Hatton A., Bloch S., Smith G., Clarke D.M., Miach P., 
Ikin J., Ranieri N., and Snyder R.D. Effect of cognitive-existential group 
therapy on survival in early-stage breast cancer. Journal of Clinical Oncology 
2004; 22(21): 4255–4260.  
- Kissane D.W., McKenzie M., McKenzie D.P., Forbes A., O'Neill I., Bloch S. 
Psychosocial morbidity associated with patterns of family functioning in 
palliative care: baseline data from the Family Focused Grief Therapy controlled 
trial. Palliat Med 2003 Sep;17(6):527-37. 
- Kissane D.W., Wein S., Love A., Lee X.Q., Kee P.L., Clarke D.M. The 
Demoralization Scale: a report of its development and preliminary validation. 
Journal of Palliative Care 2004; 20(4), 269-276 
- Kleim B. and Ehlers A. Evidence for a Curvilinear Relationship Between 
Posttraumatic Growth and Posttrauma Depression and PTSD in Assault 
Survivors Journal of Traumatic Stress, Vol. 22, No. 1, February 2009; pp. 45–
52. 
- Kleinman A.: The Illness Narratives. Suffering, Healing and the Human 
Condition. USA: Basic Books; 1988.  
- Kolokotroni P., Anagnostopoulos F., Tsikkinis A. Psychosocial factors related to 
posttraumatic growth in breast cancer survivors: a review. Women Health. 
2014;54(6):569-92.  
- Kroenke K., Spitzer R.L., Williams J.B. The PHQ-9: Validity of a brief 
depression severity measure. Journal of General Internal Medicine 2001; 16, 
606-613. 
48 
- Lee V., Cohen S.R., Edgar L., Laizner A., and Gagnon A.J. Meaning-making 
and psychological adjustment to cancer: Development of an intervention and 
pilot results. Oncology Nursing Forum 2006; 33(2): 291–302. 
- Leong Abdullah M.F., Nik Jaafar N.R., Zakaria H., Rajandram R.K., 
Mahadevan R., Mohamad Yunus M.R., Shah S.A. Posttraumatic growth, 
depression and anxiety in head and neck cancer patients: examining their 
patterns and correlations in a prospective study. Psychooncology 2015 Jan; 21.  
- Lewis S., Salins N., Rao M.R., Kadam A. Spiritual well-being and its influence 
on fatigue in patients undergoing active cancer directed treatment: a 
correlational study. J Cancer Res Ther. 2014 Jul-Sep;10(3):676-80. 
- Li M., Boquiren V., Lo C., and Rodin. G. Depression and anxiety in supportive 
oncology 2011. In: Supportive oncology, ed. M.P. Davis, P. Feyer, P. Ortner, 
and C. Zimmermann, 528–540. Philadelphia: Elsevier. 
- Linley P.A., and Joseph S. Positive change following trauma and adversity: A 
review. Journal of Traumatic Stress 2004; 17, 11-21. 
- Lo C., Burman D., Swami N., Gagliese L., Rodin G., Zimmermann C.Validation 
of the QUAL-EC for assessing quality of life in patients with advanced cancer. 
European Journal of Cancer 2010. 
- Lo C., Hales S., Jung J., Chiu A., Panday T., Rydall A., Nissim R., Malfitano C., 
Petricone-Westwood D., Zimmermann C., Rodin G. Managing Cancer And 
Living Meaningfully (CaLM): phase 2 trial of a brief individual psychotherapy 
for patients with advanced cancer. Palliat Med. 2014 Mar;28(3):234-42.  
- Lo C., Hales S., Zimmermann C., Gagliese L., Rydall A., Rodin G. Measuring 
death-related anxiety in advanced cancer: Preliminary psychometrics of the 
Death and Dying Distress Scale. Journal of Pediatric Hematology and Oncology 
2011; 33(Suppl 2) S140-145. 
49 
- Lo C., Walsh A., Mikulincer M., Gagliese L., Zimmermann C., Rodin G. 
Measuring attachment security in patients with advanced cancer: psychometric 
properties of a modified and brief Experiences in Close Relationships scale. 
Psycho-Oncology 2009; 18, 490-499.Lo C., Zimmermann C., Rydall A.C., 
Walsh A., Jones J.M., Moore M.J., Shepherd F.A., Gagliese L., and Rodin G. 
Longitudinal study of depressive symptoms in patients with metastatic 
gastrointestinal and lung cancer. Journal of Clinical Oncology 2010; 28(18), 
3084-3089. 
- López-Sierra H.E., Rodríguez-Sánchez J. The supportive roles of religion and 
spirituality in end-of-life and palliative care of patients with cancer in a 
culturally diverse context: a literature review. Curr Opin Support Palliat Care. 
2015 Mar;9(1):87-95.  
-  Maguire P. Barriers to psychological care to the dying. Br. Med. J. 
1985;291:1711-1713.  
- Manne, S., Ostroff, J., Winkel, G., Goldstein, L.K.F. and Grana, G. 
Posttraumatic growth after breast cancer: Patient, partner, and couple 
perspectives. Psychosomatic Medicine 2004;66, 442-454.  
- Massie M.J., Holland J.C. Depression and cancer patients. J Clin Psychiatry. 
1990;51:12- 19. 
- May R. The Discovery of Being. Writings in Existential Psychology. Rollo May 
W. W. Norton fcf Company. New York. London. Copyright 1983. 
- McMillen J. C., Smith E. M., and Fisher R. H. Perceived benefit and mental 
health after three types of disaster. Journal of Consulting and Clinical 
Psychology1997; 65, 733–739. 
- Mitchell A.J., Chan M., Bhatti H., Halton M., Grassi L., Johansen C., Meader 
N. Prevalence of depression, anxiety, and adjustment disorder in oncological, 
haematological, and palliative-care settings: a meta-analysis of 94 interview-
based studies. Lancet Oncol 2011; 12(2):160-74. 
50 
- Miller D.K., Chibnall J.T., Videen S.D., and Duckro P.N.. Supportive-affective 
group experience for persons with life-threatening illness: Reducing spiritual, 
psychological, and death-related distress in dying patients. Journal of Palliative 
Medicine 2005; 8(2): 333–343. 
- Morita T. 2004. Palliative sedation to relieve psycho-existential suffering of 
terminally ill cancer patients. Journal of Pain and Symptom Management 28(5): 
445–450.  
- Morita T., Kawa M., Honke Y., Kohara H., Maeyama E., Kizawa Y., Akechi T., 
Uchitomi Y. Existential concerns of terminally ill cancer patients receiving 
specialized palliative care in Japan. Support Care Cancer 2004; 12:137–140 
- Moye J., Rouse SJ. Posttraumatic stress in older adults: when medical 
diagnoses or treatments cause traumatic stress. Clin Geriatr Med. 2014 
Aug;30(3):577-89.  
- Nietzsche, F. Twilight of the Idols (Maxims and Arrows). 1888. 
- Nissim R., Freeman E., Lo C., Zimmermann C., Gagliese L., Rydall A., Hales 
S., Rodin G. Managing Cancer and Living Meaningfully (CaLM): a qualitative 
study of a brief individual psychotherapy for individuals with advanced cancer. 
Palliat Med. 2012 Jul;26(5):713-21. 
- Nissim R., Gagliese L., and Rodin G. The desire for hastened death in 
individuals with advanced cancer: A longitudinal qualitative study. Social 
Science and Medicine 2009;69, 165-171. 
- O’leary V., Alday C., and Ickovics J. Models of life change and posttraumatic 
growth. 1998. In R. Tedeschi, C. Park, and L. Calhoun (a cura di), Posttraumatic 
growth:Positive changes in the aftermath of crisis (pp. 127-151). Mahwah, NJ: 
Erlbaum.  
- Olson D.H. and Larson P.J. PREPARE/ENRICH: Customized Version. Life 
Innovations, Minneapolis. 2008. 
51 
- O'Mahony S., Goulet J., Kornblith A., Abbatiello G., Clarke B., Kless-Siegel S., 
Breitbart W., Payne R. Desire for hastened death, cancer pain and depression: 
report of a longitudinal observational study. J Pain Symptom Manage. 2005 
May;29(5):446-57.  
- Park C.L., Cohen L.H., and Murch R.L. Assessment and prediction of stress 
related growth. Journal of Personality1996; 64, 71-105. 
-  Park C. L., Fenster J. R. Stress-related growth: Predictors of occurrence and 
correlates with psychological adjustment. Journal of Social and Clinical 
Psychology 2004; 23, 195–215. 
- Passik S.D., Breitbart W.S. Depression in patients with pancreatic carcinoma: 
diagnostic and treatment issues. Cancer. 1996; 78(suppl 3):615-626. 
- Paterson C., Robertson A., Smith A., Nabi G. Identifying the unmet supportive 
care needs of men living with and beyond prostate cancer: A systematic review. 
Eur J Oncol Nurs. 2015 Jan; 19.  
- Peterman A.H., Fitchett G., Brady M.J., Hernandez L., Cella D. Measuring 
spiritual well-being in people with cancer: The functional assessment of chronic 
illness therapy - spiritual well-being scale (FACIT-Sp). Annals of Behavioral 
Medicine 2002; 24(1), 49-58. 
- Portenoy R.K. et al, The Memorial Symptom Assessment Scale: An instrument 
for the evaluation of symptom prevalence, characteristics and distress. 
European Journal of Cancer 1994; 30, 1326-1336. 
- Portnoy R.K.,  Rana P.,  Zimmermann C.,  Rodin G. The Use of Palliative 
Sedation to Treat Existential Suffering: A Reconsideration. In: Sedation at the 
End-of-life: An Interdisciplinary Approach Philosophy and Medicine 2015; pp 
41-54.  
- Rafanelli C., Roncuzzi R., Milaneschi Y., Tomba E., Colistro M.C., Pancaldi 
L.G., Di Pasquale G. Stressful life events, depression and demoralization as risk 
52 
factors for acute coronary heart disease. Psychotherapy and Psychosomatics 
2005; 74: 179-184. 
- Rodin G., Lo C., Mikulincer M., Donner A., Gagliese L., and Zimmermann C. 
Pathways to distress: The multiple determinants of depression, hopelessness and 
the desire for hastened death in metastatic cancer patients. Social Science and 
Medicine 2009; 68, 562-569.  
- Rodin G., Walsh A., Zimmermann C., Gagliese L., Jones J., Shepherd F.A., 
Moore M., Braun M., Donner A., and Mikulincer M. The contribution of 
attachment security and social support to depressive symptoms in patients with 
metastatic cancer. Psycho-Oncology 2007; 16(12), 1080-1091.  
- Rodin G., Yuen D., Mischitelle A., Minden M.D., Brandwein J., Schimmer A., 
Marmar C., Gagliese L., Lo C., Rydall A., and Zimmermann, C. 2011. 
Traumatic stress in acute leukemia. Psychooncology 2011. 
- Rodin G., Zimmermann C. Psychoanalytic reflections on mortality: A 
reconsideration. The Journal of the American Academy of Psychoanalysis and 
Dynamic Psychiatry 2008; 36(1), 181-196. 
- Rousseau P. Existential suffering and palliative sedation: A brief commentary 
with a proposal for clinical guidelines. American Journal of Hospice and 
Palliative Care 2001; 18(3):151–153. 
- Royal Dutch Medical Association (KNMG) Committee on National Guideline 
for Palliative Sedation. Guideline for Palliative Sedation. January 2009. 
- Ruijs C.D., van der Wal G., Kerkhof A.J., Onwuteaka-Philipsen B.D. 
Unbearable suffering and requests for euthanasia prospectively studied in end-
of-life cancer patients in primary care. BMC Palliat Care 2014; Dec 
23;13(1):62.  
53 
- Schildkraut J.J., Klein F.D. The classification and treatment of depressive states. 
In: Shader RI, ed Manual of Psychiatric Therapeutics. Boston, Mass: Little, 
Brown and CO. 1975. 
- Schuman-Olivier Z., Brendel D.H.., Forstein M., and Price B.H. The use of 
palliative sedation for existential distress: A psychiatric perspective. Harvard 
Review of Psychiatry 2008; 16(6): 339–351. 
- Shader RI. Demoralization revised. J Clin Psychopharmacol 2005; 25: 291-292. 
- Shakin E.J., Holland J.C. Depression and pancreatic cancer. JPain Symptom 
Manage. 1988;3:194-198. 
- Singer P. et al. Euthanasia and End of Life Care. JAMA 1999;281(2), p. 163-
168. 
- SiqVeland J., Ninaard E. et al. Posttraumatic growth, depression and 
posttraumatic stress in relation to quality of life in tsunami survivors: a 
longitudinal study.Health and Quality of Life Outcomes 2015; 13:18  
- Slavney P.R. Diagnosing demoralization in consultation psychiatry. 
Psychosomatics 1999; 40:325-329. 
- Spiegel D., and Spira J. Supportive-Expressive Group Therapy: A treatment 
manual of psychosocial intervention for women with recurrent breast cancer. 
Stanford: Stanford University School of Medicine. 1991. 
- Spitzer RL et al. A brief measure for assessing generalized anxiety disorder: the 
GAD-7. Archives of Internal Medicine 2006; 166(10), 1092-1097. 
- Steinhauser K., Clipp E.C., NcNeilly M., Christakis N.A., McIntyre L.M. and 
Tulsky J.A. In search of a good death: Observations of patients, families and 
providers. Annals of Internal Medicine2000; 132(10), 825-832. 
- Stern, D.N. The present moment in psychotherapy and everyday life. New 
York:W.W. Norton and Co. 2004. In: Rodin G, Zimmermann C Psychoanalytic 
54 
reflections on mortality: a reconsideration. J Am Acad Psychoanal Dyn 
Psychiatry 2008 Spring;36(1):181-96. 
- Strang P., Strang S., Hultborn R., Arnér S. Existential pain—an entity, a 
provocation, or a challenge? J Pain Symptom Manage 2004; 27:241–250. 
- Sumalla E.C., Ochoa C., Blanco I. Posttraumatic growth in cancer: reality or 
illusion?Clin Psychol Rev. 2009 Feb;29(1):24-33.  
- Tedeschi R.G., and Calhoun L.G. The Posttraumatic Growth Inventory: 
Measuring the positive legacy of trauma. Journal of Traumatic Stress 1996; 9, 
455-471. 
- Tedeschi R.G., and Calhoun L.G. Trauma and transformation: Growing in the 
aftermath of suffering. Thousand Oaks, CA: Sage. 1995. 
- Tedeschi R.G., Park C.L., and Calhoun L.G. (a cura di) (1998). Posttraumatic 
growth:Positive changes in the aftermath of crisis. Mahwah, NJ: Erlbaum. 
- UNESCO. International Bioethics Committee. Elaboration of the Declaration 
on Universal Norms of Bioethics: Second Outline of a Text. Paris. 2004. 
- Van der Mass P.J., van Delden J.J.M., Pijnebort L., Looman C.W.N. Euthanasia 
and other meical decisions concerning the end of life. Lancet. 1992; 338:669-
674. Vehling S., Lehmann C., Oechsle K., Bokemeyer C., Krüll A., Koch U., 
Mehnert A. Is advanced cancer associated with demoralization and lower global 
meaning? The role of tumor stage and physical problems in explaining 
existential distress in cancer patients. Psychooncology 2012; 21(1):54-63. 
- Vos J., Craig M., Cooper M. Existential therapies: A meta-analysis of their 
effects on psychological outcomes. J Consult Clin Psychol 2015 Feb;83(1):115-
28.  
- Widows M.R., Jacobsen P.B., Booth-Jones M., and Fields, K.K. Predictors of 
posttraumatic growth following bone marrow transplantation for cancer. Health 
Psychology 2005; 24, 266-273. 
55 
- Wilson K.G., Chochinov H.M., McPherson C.J., LeMay K., Allard P., Chary S., 
Gagnon P.R., Macmillan K., De Luca M., O’Shea F., Kuhl D., Fainsinger R.L. 
Suffering with advanced cancer. J Clin Oncol 2007a; 25:1691–1697. 
- Wilson K.J., Chochinov H.M., Skirko M.G., et al. Depression and anxiety 
disorders in palliative cancer care. J Pain Symptom Manage. 2007b;33:1118-
129. 
- Yalom, I.D. Existential psychotherapy. New York: Basic. 1980. 
 
 
